Search documents
HR tech firm Rippling raises new funding at $16.8 billion valuation, no IPO plans
Reuters· 2026-05-09 17:02AI Processing
Core Insights - Rippling, an HR software startup, raised $450 million in Series G funding, achieving a valuation of $16.8 billion, focusing on global revenue growth over immediate profitability [1][4][5] Funding and Valuation - The funding round included participation from notable investors such as Y Combinator, Elad Gil, Sands Capital, GIC, and Goldman Sachs Growth [2] - The new valuation of $16.8 billion marks an increase from the previous valuation of $13.5 billion in early 2024 [4] Employee Equity and IPO Plans - Rippling plans to repurchase up to $200 million of equity from current and former employees through a tender offer, which may become an annual event [2][3] - The CEO stated that the company does not have immediate plans for an IPO, emphasizing the need for profitability before considering going public [4][6] Business Performance and Strategy - Rippling has surpassed $100 million in annual recurring revenue and serves over 20,000 customers with a suite of more than 20 products [5] - The company is prioritizing growth over profitability, indicating a strategic choice to expand rapidly rather than slow down for immediate profit [6] Legal Challenges - Rippling is involved in ongoing legal disputes with competitor Deel, including allegations of corporate espionage, which have raised questions about competitive practices in the tech industry [7][8]
RH (NYSE:RH) Q4 Fiscal 2025 Earnings Preview: Key Insights and Financial Highlights
Financial Modeling Prep· 2026-03-31 01:00
Significant Short Interest: Short interest in NYSE:RH surged by 28.3%, with 35.3% of shares sold short, indicating heightened investor skepticism. Projected EPS Growth: Despite challenges, RH anticipates a 39.9% year-over-year increase in EPS to $2.21, driven by new collections and global expansion. Insider Selling Activity: Notable insider sales, including Director Mark S. Demilio and insider Eri Chaya, may signal concerns about future performance. RH (NYSE:RH) is a luxury lifestyle brand known for its cu ...
U.S. GoldMining Inc. (NASDAQ:USGO) Stock Analysis: Price Target, Exploration Progress, and Market Outlook
Financial Modeling Prep· 2026-03-31 00:00
U.S. GoldMining Inc. (NASDAQ:USGO) is an exploration stage company dedicated to the exploration and development of mineral properties in the United States, with a primary focus on the Whistler project in Alaska. As a subsidiary of GoldMining Inc., USGO operates within the gold-copper exploration sector. The company is compared to Jaguar Mining (OTCMKTS:JAGGF), another small-cap entity in the basic materials sector. Market conditions, particularly in the gold and copper sectors, are essential to consider. Pr ...
LENSAR, Inc. (NASDAQ:LNSR) Stock Analysis: Price Target, Market Position, and Key Catalysts
Financial Modeling Prep· 2026-03-31 00:00
Consensus price target for (NASDAQ:LNSR) remains steady at $10, reflecting stable analyst outlook. Earnings reports and advancements in the LENSAR Laser System are crucial factors influencing stock performance. Market trends and partnerships play a significant role in shaping LENSAR's growth prospects and analyst sentiment. LENSAR, Inc. (NASDAQ:LNSR) is a medical device company that focuses on developing and marketing the LENSAR Laser System. This system is used for cataract treatment and managing corneal ...
JD.com And Ceconomy Mega Deal Delayed By Austrian Regulators
Forbes· 2026-03-30 23:50
Austria could derail the acquisition by JD.com of Europe's biggest electricals retailer. Photo: Sebastian Gollnow/dpa (Photo by Sebastian Gollnow/picture alliance via Getty Images)dpa/picture alliance via Getty ImagesThe contest for Ceconomy, Europe’s largest consumer electricals retailer, was always about more than scale and it is now at risk of becoming a referendum on whether Europe is still open to the next phase of global retail integration, or quietly redrawing its boundaries.And Austria’s interventio ...
Caliber Announces Conversion of $15.9 Million of Preferred Equity into Common Stock
Globenewswire· 2026-03-30 23:49
SCOTTSDALE, Ariz., March 30, 2026 (GLOBE NEWSWIRE) -- Caliber (Nasdaq CWD), a diversified real estate and digital asset management platform, today announced that an institutional investor elected to convert approximately $15.9 million of perpetual convertible preferred equity into shares of the Company’s common stock. Under the original investment, Caliber issued 15,868 shares of Series B Preferred Stock at a purchase price of $1,000 per share, resulting in gross proceeds of $15,868,000. The holder has exer ...
振邦智能(003028) - 2025年度募集资金年度存放、管理与使用情况鉴证报告
2026-03-30 23:48
中国 北京 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台(http://ac.mof.gov.cn)"进行在强 。 "在"扫"或进入"注册会计师行业统一监管平台(http://ac.mof.gov.cn)"进行查题 "" " 详诚会计 RSM 容诚 募集资金年度存放、管理与使用情况鉴证报告 深圳市振邦智能科技股份有限公司 容诚专字[2026]518Z0046 号 容诚会计师事务所(特殊普通合伙) 目 录 | 序号 | 内 容 | 页码 | | --- | --- | --- | | | 募集资金年度存放、管理与使用情况鉴证报告 | 1-3 | | 2 | 募集资金年度存放、管理与使用情况专项报告 | 1-9 | in the first and 募集资金年度存放、管理与使用情况鉴证报告 容诚专字[2026]518Z0046 号 深圳市振邦智能科技股份有限公司全体股东: 我们审核了后附的深圳市振邦智能科技股份有限公司(以下简称振邦智能公 司) 董事会编制的 2025 年度《关于募集资金年度存放、管理与使用情况的专项报 告》。 一、对报告使用者和使用目的的限定 本鉴证报告仅供振邦智能公司年度报告披露之 ...
兆威机电(02692) - 海外监管公告 - 深圳市兆威机电股份有限公司2025年度会计师事务所履职...
2026-03-30 23:48
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示 概 不 就 因 本 公 告 全 部 或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 SHENZHEN ZHAOWEI MACHINERY & ELECTRONICS CO., LTD. 深圳市兆威機電股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:2692) 海外監管公告 本 公 告 乃 根 據《香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則》第13.10B條而作出。 茲 載 列 深 圳 市 兆 威 機 電 股 份 有 限 公 司(「 本公司 」)在 深 圳 證 券 交 易 所 網 站 (www.szse.cn)刊登了以下公告。茲載列如下,僅供參閱。 特此公告。 承董事會命 深圳市兆威機電股份有限公司 李海周先生 香港,2026年3月30日 於本公告日期,本公司董事會包括:(i)執行董事李海周先生、謝燕玲女士、葉曙 兵先生及李平先生;(ii)職工代表董事陸志強先生;及(iii)獨立非執行董 ...
春立医疗(01858) - 2025年年度报告

2026-03-30 23:48
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或 完整性亦不發表任何聲明,並表明概不就因本公告全部或任何部份內容而產生或因依賴該等內容 而引致的任何損失承擔任何責任。 北 京 市 春 立 正 達 醫 療 器 械 股 份 有 限 公 司 Beijing Chunlizhengda Medical Instruments Co., Ltd.* ( 於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司 ) (股 份 代 號:1858) 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條由北京市春立正 達醫療器械股份有限公司(「本公司」)作出。 茲載列本公司在上海證券交易所網站刊登之《2025年年度報告》,僅供參閱。 承董事會命 北京市春立正達醫療器械股份有限公司 董事長 史文玲 中國北京,2026年3月31日 截至本公告日期,本公司執行董事為史文玲女士、史春寶先生、岳術俊女士及解鳳寶先生;本公 司非執行董事為王鑫先生;及本公司獨立非執行董事為徐泓女士、翁杰先生及黃德盛先生。 * 僅供識別 北京市春立正达医疗器械股份有限公司2025 ...
迈瑞医疗(300760) - 一图读懂迈瑞医疗2025年度报告
2026-03-30 23:46
mindra 图 演 节 E 如 日 2025.05 @ 2025.09 2025.11 2026.03 公司实施 2025 年第一次中期分红 派发现金股利 17.10亿元 (含税 ) 公司实施 2025 年第二次中期分红 派发现金股利 15.88亿元 (含税 ) 公司实施 2025 年第三次中期分红 派发现金股利 16.37 亿元 ( 含税 ) 公司计划实施 2025 年度利润分配预案 拟派发现金股利 3.76 亿元 ( 含税 ) | 2025年累计分红金额 53.10亿元(含税) | | | | | --- | --- | --- | --- | | 2025年分红比例 65.27% | | | 单位:百分比 分红总额 / 归母净利润 | | 56.8 | 60.7 | 65.1 | 65.3 | | 2022 | 2023 | 2024 | 2025 | 国际鹏程正展 国内前路日明 2025年全年 | 营业收入 | | --- | | 332.82亿元 同比下降9.38% | | 净利润 | | 84.51 亿元 同比下降28.01% | | 扣非净利润 | | 83.62 亿元 同比下降27.28% ...